Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

115 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Improving diagnosis coding in the ProMise database: Guidelines of the Francophone society of bone marrow transplantation and cellular therapy (SFGM-TC)].
Polge E, Bourgue F, Cuvelier M, Pires B, Hugon N, Laurent N, Leclerc N, Leroux S, Le Bars L, Marion S, Meziane Y, Moukhtari L, Renault M, Peffault de Latour R, Yakoub-Agha I, Raus N. Polge E, et al. Among authors: laurent n. Bull Cancer. 2016 Nov;103(11S):S213-S219. doi: 10.1016/j.bulcan.2016.09.009. Epub 2016 Nov 11. Bull Cancer. 2016. PMID: 27842859 French.
[Harmonization of data coding in post-transplant follow-up - "GVHD, complications and additional treatments": Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Cornillon J, Detrait M, Karam M, Le Bars L, Meziane Y, Pereira M, Richard-Leveille S, Marion S, Leroux S, Coiteux V, Raus N, Seris S, Guyotat D, Yakoub-Agha I, Laurent N. Cornillon J, et al. Among authors: laurent n. Bull Cancer. 2019 Jan;106(1S):S71-S82. doi: 10.1016/j.bulcan.2018.10.003. Epub 2018 Nov 15. Bull Cancer. 2019. PMID: 30448095 French.
Bioequivalence Between a New Omalizumab Prefilled Syringe With an Autoinjector or with a Needle Safety Device Compared with the Current Prefilled Syringe: A Randomized Controlled Trial in Healthy Volunteers.
Sangana R, Xu Y, Shah B, Tian X, Zack J, Shakeri-Nejad K, Kalluri S, Jones I, Ligueros-Saylan M, Taylor AF, Jain DK, Scosyrev E, Uddin A, Laurent N, Paganoni P. Sangana R, et al. Among authors: laurent n. Clin Pharmacol Drug Dev. 2024 Jun;13(6):611-620. doi: 10.1002/cpdd.1373. Epub 2024 Feb 22. Clin Pharmacol Drug Dev. 2024. PMID: 38389387 Clinical Trial.
Comprehensive Assessment of Pharmacokinetics, Pharmacodynamics, and Tolerability of Ligelizumab in Healthy Volunteers and Patients with Chronic Spontaneous Urticaria to Optimize Its Subcutaneous Delivery System.
Ji Y, Calonder C, Kirsilä T, Burciu A, Tisu M, Joubert Y, Laurent N, Hua E, Patekar M, Drollmann A, Woessner R. Ji Y, et al. Among authors: laurent n. Pharmaceutics. 2023 Sep 1;15(9):2266. doi: 10.3390/pharmaceutics15092266. Pharmaceutics. 2023. PMID: 37765235 Free PMC article.
Clinically Translatable Transcrocetin Delivery Platform for Correction of Tumor Hypoxia and Enhancement of Radiation Therapy Effects.
Diringer MC, Coliat P, Mathieu C, Laurent N, Mura C, Banerjee M, Zhu C, Grabowska A, Ritchie A, Clarke P, Bernard A, Vit C, Burckel H, Noel G, Harvey P, Pivot X, Detappe A. Diringer MC, et al. Among authors: laurent n. Small. 2023 Mar;19(12):e2205961. doi: 10.1002/smll.202205961. Epub 2023 Jan 1. Small. 2023. PMID: 36587987
115 results